Get the Stockscreener App
3.95
7.49%
-0.32
After Hours:
3.95
Burning Rock Biotech Ltd Adr Stock (BNR) Forecast
The Burning Rock Biotech Ltd Adr (BNR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13.40, representing a +239.14% increase from the current price of $3.95. The highest analyst price target is $20.17, and the lowest is $6.6209.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BNR Price Target
Average 10.20
(+158.33% Upside)
Is Burning Rock Biotech Ltd Adr (BNR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.42 | Buy |
| STOCH(9,6) | 6.4437 | Buy |
| STOCHRSI(14) | 10.64 | Buy |
| MACD(12,26) | -0.5106 | Sell |
| ADX(14) | 23.48 | Neutral |
| William %R | -97.29 | Buy |
| CCI(14) | -150.62 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.706
Sell
|
4.6169
Sell
|
| MA20 |
5.1012
Sell
|
5.0436
Sell
|
| MA50 |
5.9902
Sell
|
5.6091
Sell
|
| MA100 |
5.8672
Sell
|
5.7234
Sell
|
| MA200 |
5.5794
Sell
|
6.0697
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BNR could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on BNR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.42 indicates that BNR is oversold. This indicates that BNR price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 6.4437 indicates that BNR is oversold. This indicates that BNR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.64 indicates that BNR is oversold. This suggests that BNR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.48 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -150.62 indicates that BNR is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term BNR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Burning Rock Biotech Ltd Adr financial reports and earnings history, Burning Rock Biotech Ltd Adr (BNR) stock could reach $12.24 by 2030, $42.29 by 2040 and $30.55 by 2050. See the projected annual prices until 2050 of the Burning Rock Biotech Ltd Adr stock below:
- Burning Rock Biotech Ltd Adr (BNR) is expected to reach an average price of $34.04 in 2035, with a high prediction of $33.83 and a low estimate of $34.52. This indicates an $761.87% rise from the last recorded price of $3.95.
- Burning Rock Biotech Ltd Adr (BNR) stock is projected to chart a bullish course in 2040, with an average price target of $40.71, representing an $930.71% surge from its current level. The forecast ranges from a conservative $41.34 to a sky-high $42.29.
- Our analysts predict Burning Rock Biotech Ltd Adr (BNR) to jump 854.61% by 2045, soaring from $37.87 to an average price of $37.71, potentially reaching $38.75. While $37.87 is the low estimate, the potential upside is significant.
- Burning Rock Biotech Ltd Adr (BNR) stock is expected to climb by 2050, reaching an average of $29.47, a $645.97% jump from its current level. However, a wide range of estimates exists, with high and low targets of $30.55 and $29.54, respectively, highlighting the market's uncertainty.
Burning Rock Biotech Ltd Adr Stock (BNR) Year by Year Forecast
Burning Rock Biotech Ltd Adr Stock (BNR) Price Forecast for 2025
Burning Rock Biotech Ltd Adr Stock (BNR) is expected to reach an average price of $10.20 in 2025, with a high prediction of $20.17 and a low estimate of $0.2366. This indicates an +158.33% rise from the last recorded price of $3.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $8.7014 | $6.6209 | $20.17 | +120.29% |
| June, 2025 | $12.10 | $7.8417 | $12.19 | +206.39% |
| July, 2025 | $9.1336 | $8.4431 | $12.63 | +131.23% |
| August, 2025 | $2.6546 | $1.1539 | $8.7439 | -32.79% |
| September, 2025 | $3.7456 | $0.6951 | $5.2549 | -5.17% |
| October, 2025 | $0.1468 | $0.2366 | $4.1959 | -96.28% |
| November, 2025 | $1.0422 | $1.7222 | $1.2671 | -73.62% |
| December, 2025 | $3.0009 | $1.9014 | $2.2036 | -24.03% |
Burning Rock Biotech Ltd Adr Stock (BNR) Price Forecast for 2026
The predicted value for Burning Rock Biotech Ltd Adr (BNR) in 2026 is set at an average of $6.7395. Estimates vary from a peak of $9.763 to a trough of $3.716, indicating an +70.62% surge from the present price of $3.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.3299 | $3.9307 | $3.9349 | +34.94% |
| February, 2026 | $6.209 | $5.5892 | $4.8807 | +57.19% |
| March, 2026 | $5.928 | $5.9587 | $5.598 | +50.08% |
| April, 2026 | $4.3267 | $5.6675 | $5.767 | +9.54% |
| May, 2026 | $4.2257 | $3.716 | $3.4562 | +6.98% |
| June, 2026 | $8.5048 | $6.1455 | $6.8748 | +115.31% |
| July, 2026 | $9.9135 | $9.4245 | $9.7435 | +150.98% |
| August, 2026 | $8.9425 | $9.6025 | $9.763 | +126.39% |
| September, 2026 | $8.1613 | $8.3113 | $9.0724 | +106.62% |
| October, 2026 | $7.8803 | $7.5606 | $7.6911 | +99.50% |
| November, 2026 | $7.3093 | $7.5943 | $6.8993 | +85.05% |
| December, 2026 | $7.9281 | $7.7891 | $7.7983 | +100.71% |
Burning Rock Biotech Ltd Adr Stock (BNR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Burning Rock Biotech Ltd Adr (BNR) is $5.6665, with a high forecast of $7.8478 and a low forecast of $3.4852. This indicates an +43.46% increase from the last price of $3.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.3471 | $7.8221 | $7.8478 | +86.00% |
| February, 2027 | $6.7061 | $6.7461 | $6.9916 | +69.78% |
| March, 2027 | $6.0649 | $6.4956 | $6.5851 | +53.54% |
| April, 2027 | $5.4339 | $5.3844 | $5.1846 | +37.57% |
| May, 2027 | $5.0429 | $5.1531 | $4.9636 | +27.67% |
| June, 2027 | $4.5417 | $4.6417 | $4.4919 | +14.98% |
| July, 2027 | $4.1907 | $4.3007 | $4.3314 | +6.09% |
| August, 2027 | $3.9397 | $3.9302 | $3.7297 | -0.26% |
| September, 2027 | $3.6385 | $3.8592 | $3.6487 | -7.89% |
| October, 2027 | $3.5975 | $3.6175 | $3.668 | -8.92% |
| November, 2027 | $3.5365 | $3.577 | $3.3667 | -10.47% |
| December, 2027 | $3.4652 | $3.4852 | $3.5657 | -12.27% |
Burning Rock Biotech Ltd Adr Stock (BNR) Price Forecast for 2028
In 2028, Burning Rock Biotech Ltd Adr (BNR) is projected to reach an average price of $11.42, with a high projection of $22.76 and a low estimate of $0.0854. This indicates an +189.17% rise from the last price of $3.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4643 | $3.5193 | $3.4945 | -12.30% |
| February, 2028 | $2.9783 | $3.0233 | $3.334 | -24.60% |
| March, 2028 | $2.642 | $2.6441 | $2.853 | -33.11% |
| April, 2028 | $2.3807 | $2.393 | $2.5118 | -39.73% |
| May, 2028 | $1.7293 | $1.7498 | $2.2508 | -56.22% |
| June, 2028 | $1.373 | $1.4288 | $1.5497 | -65.24% |
| July, 2028 | $1.0197 | $1.0197 | $1.2464 | -74.18% |
| August, 2028 | $0.6166 | $0.6346 | $0.8707 | -84.39% |
| September, 2028 | $0.1705 | $0.1976 | $0.3964 | -95.68% |
| October, 2028 | $19.51 | $0.0854 | $21.39 | +394.01% |
| November, 2028 | $22.55 | $20.09 | $19.18 | +470.91% |
| December, 2028 | $22.96 | $22.34 | $22.76 | +481.24% |
Burning Rock Biotech Ltd Adr Stock (BNR) Price Forecast for 2029
The 2029 price forecast for Burning Rock Biotech Ltd Adr Stock (BNR) is $14.38 on average, with a high prediction of $23.14 and a low estimate of $5.625. This represents an +264.07% increase from the previous price of $3.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $21.85 | $22.23 | $23.14 | +453.07% |
| February, 2029 | $17.25 | $19.46 | $21.66 | +336.82% |
| March, 2029 | $13.91 | $14.35 | $14.29 | +252.21% |
| April, 2029 | $13.66 | $15.04 | $13.34 | +245.84% |
| May, 2029 | $17.89 | $16.78 | $15.85 | +352.86% |
| June, 2029 | $10.18 | $7.5066 | $15.25 | +157.62% |
| July, 2029 | $3.5541 | $8.5441 | $6.3156 | -10.02% |
| August, 2029 | $11.62 | $5.7736 | $12.98 | +194.22% |
| September, 2029 | $8.3896 | $9.4396 | $8.8561 | +112.40% |
| October, 2029 | $9.6672 | $5.625 | $7.0392 | +144.74% |
| November, 2029 | $5.8652 | $9.2252 | $7.9167 | +48.49% |
| December, 2029 | $7.3832 | $6.7247 | $6.5332 | +86.92% |
Burning Rock Biotech Ltd Adr Stock (BNR) Price Forecast for 2030
Burning Rock Biotech Ltd Adr Stock (BNR) is expected to reach an average price of $15.45 in 2030, with a high forecast of $22.01 and a low forecast of $8.8827. This signifies an +291.02% surge from the last price of $3.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.41 | $8.8827 | $12.24 | +264.83% |
| February, 2030 | $12.92 | $14.29 | $13.39 | +227.06% |
| March, 2030 | $15.56 | $14.28 | $14.63 | +293.84% |
| April, 2030 | $17.66 | $16.70 | $16.94 | +347.21% |
| May, 2030 | $15.26 | $17.33 | $16.25 | +286.39% |
| June, 2030 | $19.42 | $18.78 | $18.71 | +391.66% |
| July, 2030 | $20.67 | $20.15 | $19.54 | +423.24% |
| August, 2030 | $19.99 | $20.26 | $19.66 | +405.97% |
| September, 2030 | $19.89 | $19.52 | $19.42 | +403.64% |
| October, 2030 | $17.38 | $16.97 | $17.41 | +340.04% |
| November, 2030 | $21.26 | $19.20 | $19.63 | +438.22% |
| December, 2030 | $22.31 | $22.08 | $22.01 | +464.75% |
3.14%
1.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):